G.ST Antivirals
About:
G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals against infections of the respiratory tract.
Website: https://www.gst-antivirals.com/
Top Investors: xista science ventures, Lansdowne Partners
Description:
G.ST Antivirals is a clinical-stage biotech company that applies an innovative host cell-based strategy to develop broad-spectrum antivirals against infections of the respiratory tract.
Total Funding Amount:
8.7M EUR
Headquarters Location:
Vienna, Wien, Austria
Founded Date:
2019-10-01
Contact Email:
office(AT)gst-antivirals.com
Founders:
Guido Gualdoni, Johannes Stöckl
Number of Employees:
11-50
Last Funding Date:
2024-01-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai